Emergent Health Corp
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxyg… Read more
Emergent Health Corp (EMGE) - Total Assets
Latest total assets as of September 2024: $209.16K USD
Based on the latest financial reports, Emergent Health Corp (EMGE) holds total assets worth $209.16K USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Emergent Health Corp - Total Assets Trend (2010–2023)
This chart illustrates how Emergent Health Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Emergent Health Corp - Asset Composition Analysis
Current Asset Composition (December 2023)
Emergent Health Corp's total assets of $209.16K consist of 74.2% current assets and 25.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $86.06K | 16.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2023)
This chart illustrates how Emergent Health Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Emergent Health Corp's current assets represent 74.2% of total assets in 2023, a decrease from 100.0% in 2010.
- Cash Position: Cash and equivalents constituted 4.7% of total assets in 2023, down from 93.4% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is intangible assets at 16.1% of total assets.
Emergent Health Corp Competitors by Total Assets
Key competitors of Emergent Health Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Emergent Health Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Emergent Health Corp generates 3.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Emergent Health Corp is currently not profitable relative to its asset base.
Emergent Health Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.04 | 0.16 | 9.35 |
| Quick Ratio | 0.04 | 0.16 | 9.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.23 Million | $ -2.24 Million | $ 943.63K |
Emergent Health Corp - Advanced Valuation Insights
This section examines the relationship between Emergent Health Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -32.5% |
| Total Assets | $533.70K |
| Market Capitalization | $9.14 USD |
Valuation Analysis
Below Book Valuation: The market values Emergent Health Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Emergent Health Corp's assets decreased by 32.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Emergent Health Corp (2010–2023)
The table below shows the annual total assets of Emergent Health Corp from 2010 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $533.70K | -32.46% |
| 2022-12-31 | $790.21K | +108.57% |
| 2021-12-31 | $378.88K | +17.86% |
| 2020-12-31 | $321.48K | -20.42% |
| 2019-12-31 | $403.96K | -60.87% |
| 2013-12-31 | $1.03 Million | +113895.10% |
| 2012-12-31 | $905.71 | -99.91% |
| 2011-12-31 | $1.06 Million | +150.27% |
| 2010-12-31 | $422.17K | -- |